Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.
Nifedipine is a calcium channel blocker of the dihydropyridine group: it relaxes the muscle of artery walls, so they widen and blood pressure falls. As extended-release tablets it treats high blood pressure and angina; it is also used for high blood pressure in pregnancy, to delay preterm labour, and for Raynaud's phenomenon. It is sold as Procardia and Adalat, among other names.
Nifedipine is broken down almost entirely by CYP3A4 (and CYP3A5), which is why grapefruit and other CYP3A4 blockers raise its levels. Studies have looked at CYP3A4 and CYP3A5 variants for its levels, and at the calcium channel gene CACNA1C, ADRA1A and SLC14A2 for blood pressure response. The findings come from a few studies, and there is no CPIC or DPWG guideline.
Every published finding on gene variants and Procardia. Upload your DNA file to see which of these rows apply to you.
PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.
SLC14A2 rs1123617: Level 3. Efficacy: Hypertension. 1.
SLC14A2 rs3745009: Level 3. Efficacy: Hypertension. 1.
CYP3A5 rs776746: Level 3. Other: Pregnancy. 1.
CYP3A4 CYP3A4*1, CYP3A4*17: Level 3. Metabolism/PK. 1.
Studies of how quickly the body processes this medication.
Studies of how well it worked in people carrying a variant.
Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.
More drugs from the same category
Calan (Calcium Channel Blockers)
Calcium Channel Blockers (class) (Calcium Channel Blockers)
Cardene (Calcium Channel Blockers)
Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.
Content updated September 2026.
ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.
Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026
Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com